Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
Diatrizoate
Latest prescription information about Diatrizoate. Learn how to pronounce the drug’s name, its indications, dosage, how to take, when to take, when not to take, side effects, special precautions, its storage instructions and warnings if any when taken during pregnancy. Also listed are the International and Indian trade name(s) of the drug and its price list.
|
Generic Name : Diatrizoate
Pronunciation : dye-uh-TRY-zoh-ate
Therapeutic Classification : Diagnostic Agents
ICD Code : Y57.6
Trade Name(s): International- Gastrografin, MD-Gastroview. Why it is prescribed (Indications) : This medication is a radiocontrast agent, prescribed for radiographic examination of the gastrointestinal tract. When it is not to be taken (Contraindications): Contraindicated in pregnant women.
Dosage & When it is to be taken : Adults - Oral, from 90 mL to 180 mL of a 25 to 40 percent solution. Enema, from 500 mL to 1000 mL of a 15 to 25 percent solution. Infants and Children - Oral, from 30 mL to 75 mL of a 20 to 40 percent solution. Enema, from 100 mL to 500 mL of a 10 to 15 percent solution, depending on weight of patient. How it should be taken : It comes as a powder (to be diluted with fluid) to take by mouth usually 15 to 30 minutes prior to test procedure. Warnings and Precautions : * Caution should be exercised in patients with history of thyroid problems (e.g., hyperthyroid, goiter), stomach problems, dehydration, electrolyte imbalance, liver or kidney impairment, emotional stress, any allergy, children, during breastfeeding. Side Effects : Nausea, vomiting, diarrhea, stomach cramps, rash, itching. * Avoid excess dosage. Storage Conditions : Store it at room temperature (15 to 25°C). |
 Comment & Contribute
| ||
Browse the Drugs alphabetically
Reference
- Food and Drug Administration (FDA)
- National Institutes of Health (NIH)
- PubMed
- CIMS
- Indian Pharma Reference Guide 2012
Ask an Expert
